BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The BCR-ABL fusion protein drives the malignant proliferation of myeloid stem cells and has been shown to be a major pathogenetic mechanism in chronic myelogenous leukemia (CML) [187].